Truvian

Truvian Sciences is a healthcare company at the intersection of diagnostics and consumer tech.

Truvian is developing an FDA-cleared automated system that produces lab-accurate results for a full suite of health tests from a single, small sample of blood.

Truvian Sciences was founded in 2015 and is headquartered in San Diego, California.

Truvian's compact, automated system rapidly produces lab-accurate results for a full suite of tests from a small sample of blood, giving individuals unprecedented access to information that shapes their health.

Truvian's automated benchtop system is being developed to produce lab-accurate results for a full-suite of health tests using a small sample of blood. Powered by patented technologies and intelligent integration, Truvian’s system delivers a convenient and affordable alternative to off-site labs, providing immediate insights to inform healthcare decisions.

 

Truvian is building a future of predictive medicine — a future in which individuals, with their healthcare providers, have information they need, when they need it, to stop disease before it starts.

 

Truvian is backed by TYH Ventures, General Catalyst, GreatPoint Ventures, DNS Capital, Tao Capital Partners, Glen Tullman of 7wireVentures, Domain Associates and others. The company raised $105M in Series C round on Feb 24, 2021. This brings Truvian's total funding to $151.3M to date.

 

 

  • Year founded: 2015
  • Funding Info: $151.3M over 5 Rounds (Latest Funding Type: Series C)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: San Diego
  • State: California
  • Country: United States
Related businesses